Report Detail
Global Paclitaxel Drug-Eluting Balloon Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4688192 |
- 27 April, 2026 |
- Global |
- 109 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Paclitaxel Drug-Eluting Balloon market size was valued at US$ 1564 million in 2025 and is forecast to a readjusted size of US$ 3556 million by 2032 with a CAGR of 12.3% during review period.
Paclitaxel drug-eluting balloons (often referred to as paclitaxel drug-coated balloons, DCBs) are endovascular angioplasty balloons coated with paclitaxel plus an excipient/carrier system engineered for rapid, localized drug transfer. During inflation, the device delivers mechanical lumen gain while depositing paclitaxel into the vessel wall to inhibit smooth-muscle cell proliferation and migration, thereby reducing restenosis and repeat interventions. The clinical and commercial proposition centers on “leave nothing behind”: achieving durable antiproliferative effect without a permanent implant, which helps avoid the long-term burden of metallic scaffolds such as chronic inflammation, imaging artifacts, and constraints on future revascularization. Paclitaxel DEBs are particularly relevant in peripheral arterial disease (e.g., femoropopliteal lesions), dialysis access maintenance, and selected coronary scenarios including in-stent restenosis and small-vessel disease. Differentiation increasingly hinges on drug crystallinity, coating integrity, and transfer efficiency enabled by manufacturing know-how.In 2025, global Paclitaxel drug-eluting balloons production reached approximately 1528 k units and price is 995 USD/Unit.The average gross profit margin of this product is 73%.
Growth is shifting from “device substitution” toward broader adoption of a standardized vascular-repair strategy. The regulatory and evidence boundary has become clearer: the U.S. FDA updated its communication noting that the totality of available data does not support an excess mortality risk for paclitaxel-coated devices used to treat PAD, enabling more actionable hospital governance and pathway deployment. In parallel, leading multinationals continue to highlight the momentum and acceptance of drug-coated balloon portfolios in annual reporting, underscoring rising strategic weight as peripheral intervention evolves “from implants to repair.”
The main hurdle is no longer “does it work,” but “can it scale compliantly and sustainably.” Although paclitaxel safety concerns have substantially de-risked, long-term follow-up and real-world evidence will remain under scrutiny—making lifecycle risk management and manufacturing consistency non-negotiable. Meanwhile, procurement and cost-containment mechanisms intensify competition beyond performance into supply assurance and quality systems; in China, centralized procurement dynamics accelerate a more rules-based, scale-driven market phase, pushing manufacturers to harden cost efficiency, delivery reliability, and compliance capabilities.
Demand is moving toward “adjunct devices + repeatable technique.” Clinicians increasingly integrate lesion preparation, optimized drug transfer, and long-term outcomes into a single procedural narrative, strengthening combination use of paclitaxel DEBs with atherectomy/plaque-modification tools, specialty scoring balloons, and intravascular imaging (IVUS/OCT). At the same time, high-recurrence, reintervention-sensitive settings (e.g., femoropopliteal disease and dialysis access) favor an implant-avoidance philosophy, broadening hospital-level adoption of the “leave nothing behind” value proposition.
Upstream differentiation is ultimately a coupled “materials + process chain” capability. Key inputs include balloon and catheter polymers (films, multi-durometer shafts, liners, and reinforcement braids/coils), paclitaxel API with crystallinity control, excipient/carrier systems and coating solvents, lubricious/hydrophilic surface coatings, plus sterile barrier packaging and sterilization services. Compared with standard PTA balloons, paclitaxel DEBs are far more sensitive to coating integrity, particulate control, batch-to-batch dose consistency, and stability—requiring medical-grade traceability, rigorous change control, clean manufacturing, and deeper co-development/validation lock-in with upstream partners.
This report is a detailed and comprehensive analysis for global Paclitaxel Drug-Eluting Balloon market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Paclitaxel Drug-Eluting Balloon market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Paclitaxel Drug-Eluting Balloon market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Paclitaxel Drug-Eluting Balloon market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Paclitaxel Drug-Eluting Balloon market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Paclitaxel Drug-Eluting Balloon
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Paclitaxel Drug-Eluting Balloon market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include B. Braun, Medtronic, Boston Scientific, BD, Yinyi Biotechnology, Acotec, Philips, Lepu Medical, Eurocor, MicroPort Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Paclitaxel Drug-Eluting Balloon market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Peripheral DEB
Coronary DEB
Market segment by Use Scenario
In-Stent Restenosi
De Novo
Small Vessel
Market segment by Balloon Platform Mechanics
Semi-/Compliant
Non-compliant
Other
Market segment by Application
Cardiac Catheterization Lab
Hospital
Other
Major players covered
B. Braun
Medtronic
Boston Scientific
BD
Yinyi Biotechnology
Acotec
Philips
Lepu Medical
Eurocor
MicroPort Medical
Teleflex
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Paclitaxel Drug-Eluting Balloon product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Paclitaxel Drug-Eluting Balloon, with price, sales quantity, revenue, and global market share of Paclitaxel Drug-Eluting Balloon from 2021 to 2026.
Chapter 3, the Paclitaxel Drug-Eluting Balloon competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Paclitaxel Drug-Eluting Balloon breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Paclitaxel Drug-Eluting Balloon market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Paclitaxel Drug-Eluting Balloon.
Chapter 14 and 15, to describe Paclitaxel Drug-Eluting Balloon sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Paclitaxel Drug-Eluting Balloon Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Peripheral DEB
- 1.3.3 Coronary DEB
- 1.4 Market Analysis by Use Scenario
- 1.4.1 Overview: Global Paclitaxel Drug-Eluting Balloon Consumption Value by Use Scenario: 2021 Versus 2025 Versus 2032
- 1.4.2 In-Stent Restenosi
- 1.4.3 De Novo
- 1.4.4 Small Vessel
- 1.5 Market Analysis by Balloon Platform Mechanics
- 1.5.1 Overview: Global Paclitaxel Drug-Eluting Balloon Consumption Value by Balloon Platform Mechanics: 2021 Versus 2025 Versus 2032
- 1.5.2 Semi-/Compliant
- 1.5.3 Non-compliant
- 1.5.4 Other
- 1.6 Market Analysis by Application
- 1.6.1 Overview: Global Paclitaxel Drug-Eluting Balloon Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Cardiac Catheterization Lab
- 1.6.3 Hospital
- 1.6.4 Other
- 1.7 Global Paclitaxel Drug-Eluting Balloon Market Size & Forecast
- 1.7.1 Global Paclitaxel Drug-Eluting Balloon Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Paclitaxel Drug-Eluting Balloon Sales Quantity (2021-2032)
- 1.7.3 Global Paclitaxel Drug-Eluting Balloon Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 B. Braun
- 2.1.1 B. Braun Details
- 2.1.2 B. Braun Major Business
- 2.1.3 B. Braun Paclitaxel Drug-Eluting Balloon Product and Services
- 2.1.4 B. Braun Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 B. Braun Recent Developments/Updates
- 2.2 Medtronic
- 2.2.1 Medtronic Details
- 2.2.2 Medtronic Major Business
- 2.2.3 Medtronic Paclitaxel Drug-Eluting Balloon Product and Services
- 2.2.4 Medtronic Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Medtronic Recent Developments/Updates
- 2.3 Boston Scientific
- 2.3.1 Boston Scientific Details
- 2.3.2 Boston Scientific Major Business
- 2.3.3 Boston Scientific Paclitaxel Drug-Eluting Balloon Product and Services
- 2.3.4 Boston Scientific Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Boston Scientific Recent Developments/Updates
- 2.4 BD
- 2.4.1 BD Details
- 2.4.2 BD Major Business
- 2.4.3 BD Paclitaxel Drug-Eluting Balloon Product and Services
- 2.4.4 BD Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 BD Recent Developments/Updates
- 2.5 Yinyi Biotechnology
- 2.5.1 Yinyi Biotechnology Details
- 2.5.2 Yinyi Biotechnology Major Business
- 2.5.3 Yinyi Biotechnology Paclitaxel Drug-Eluting Balloon Product and Services
- 2.5.4 Yinyi Biotechnology Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Yinyi Biotechnology Recent Developments/Updates
- 2.6 Acotec
- 2.6.1 Acotec Details
- 2.6.2 Acotec Major Business
- 2.6.3 Acotec Paclitaxel Drug-Eluting Balloon Product and Services
- 2.6.4 Acotec Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Acotec Recent Developments/Updates
- 2.7 Philips
- 2.7.1 Philips Details
- 2.7.2 Philips Major Business
- 2.7.3 Philips Paclitaxel Drug-Eluting Balloon Product and Services
- 2.7.4 Philips Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Philips Recent Developments/Updates
- 2.8 Lepu Medical
- 2.8.1 Lepu Medical Details
- 2.8.2 Lepu Medical Major Business
- 2.8.3 Lepu Medical Paclitaxel Drug-Eluting Balloon Product and Services
- 2.8.4 Lepu Medical Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Lepu Medical Recent Developments/Updates
- 2.9 Eurocor
- 2.9.1 Eurocor Details
- 2.9.2 Eurocor Major Business
- 2.9.3 Eurocor Paclitaxel Drug-Eluting Balloon Product and Services
- 2.9.4 Eurocor Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Eurocor Recent Developments/Updates
- 2.10 MicroPort Medical
- 2.10.1 MicroPort Medical Details
- 2.10.2 MicroPort Medical Major Business
- 2.10.3 MicroPort Medical Paclitaxel Drug-Eluting Balloon Product and Services
- 2.10.4 MicroPort Medical Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 MicroPort Medical Recent Developments/Updates
- 2.11 Teleflex
- 2.11.1 Teleflex Details
- 2.11.2 Teleflex Major Business
- 2.11.3 Teleflex Paclitaxel Drug-Eluting Balloon Product and Services
- 2.11.4 Teleflex Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Teleflex Recent Developments/Updates
3 Competitive Environment: Paclitaxel Drug-Eluting Balloon by Manufacturer
- 3.1 Global Paclitaxel Drug-Eluting Balloon Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Paclitaxel Drug-Eluting Balloon Revenue by Manufacturer (2021-2026)
- 3.3 Global Paclitaxel Drug-Eluting Balloon Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Paclitaxel Drug-Eluting Balloon by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Paclitaxel Drug-Eluting Balloon Manufacturer Market Share in 2025
- 3.4.3 Top 6 Paclitaxel Drug-Eluting Balloon Manufacturer Market Share in 2025
- 3.5 Paclitaxel Drug-Eluting Balloon Market: Overall Company Footprint Analysis
- 3.5.1 Paclitaxel Drug-Eluting Balloon Market: Region Footprint
- 3.5.2 Paclitaxel Drug-Eluting Balloon Market: Company Product Type Footprint
- 3.5.3 Paclitaxel Drug-Eluting Balloon Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Paclitaxel Drug-Eluting Balloon Market Size by Region
- 4.1.1 Global Paclitaxel Drug-Eluting Balloon Sales Quantity by Region (2021-2032)
- 4.1.2 Global Paclitaxel Drug-Eluting Balloon Consumption Value by Region (2021-2032)
- 4.1.3 Global Paclitaxel Drug-Eluting Balloon Average Price by Region (2021-2032)
- 4.2 North America Paclitaxel Drug-Eluting Balloon Consumption Value (2021-2032)
- 4.3 Europe Paclitaxel Drug-Eluting Balloon Consumption Value (2021-2032)
- 4.4 Asia-Pacific Paclitaxel Drug-Eluting Balloon Consumption Value (2021-2032)
- 4.5 South America Paclitaxel Drug-Eluting Balloon Consumption Value (2021-2032)
- 4.6 Middle East & Africa Paclitaxel Drug-Eluting Balloon Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2021-2032)
- 5.2 Global Paclitaxel Drug-Eluting Balloon Consumption Value by Type (2021-2032)
- 5.3 Global Paclitaxel Drug-Eluting Balloon Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2021-2032)
- 6.2 Global Paclitaxel Drug-Eluting Balloon Consumption Value by Application (2021-2032)
- 6.3 Global Paclitaxel Drug-Eluting Balloon Average Price by Application (2021-2032)
7 North America
- 7.1 North America Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2021-2032)
- 7.2 North America Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2021-2032)
- 7.3 North America Paclitaxel Drug-Eluting Balloon Market Size by Country
- 7.3.1 North America Paclitaxel Drug-Eluting Balloon Sales Quantity by Country (2021-2032)
- 7.3.2 North America Paclitaxel Drug-Eluting Balloon Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2021-2032)
- 8.2 Europe Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2021-2032)
- 8.3 Europe Paclitaxel Drug-Eluting Balloon Market Size by Country
- 8.3.1 Europe Paclitaxel Drug-Eluting Balloon Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Paclitaxel Drug-Eluting Balloon Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Paclitaxel Drug-Eluting Balloon Market Size by Region
- 9.3.1 Asia-Pacific Paclitaxel Drug-Eluting Balloon Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Paclitaxel Drug-Eluting Balloon Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2021-2032)
- 10.2 South America Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2021-2032)
- 10.3 South America Paclitaxel Drug-Eluting Balloon Market Size by Country
- 10.3.1 South America Paclitaxel Drug-Eluting Balloon Sales Quantity by Country (2021-2032)
- 10.3.2 South America Paclitaxel Drug-Eluting Balloon Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Paclitaxel Drug-Eluting Balloon Market Size by Country
- 11.3.1 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Paclitaxel Drug-Eluting Balloon Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Paclitaxel Drug-Eluting Balloon Market Drivers
- 12.2 Paclitaxel Drug-Eluting Balloon Market Restraints
- 12.3 Paclitaxel Drug-Eluting Balloon Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Paclitaxel Drug-Eluting Balloon and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Paclitaxel Drug-Eluting Balloon
- 13.3 Paclitaxel Drug-Eluting Balloon Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Paclitaxel Drug-Eluting Balloon Typical Distributors
- 14.3 Paclitaxel Drug-Eluting Balloon Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Paclitaxel Drug-Eluting Balloon. Industry analysis & Market Report on Paclitaxel Drug-Eluting Balloon is a syndicated market report, published as Global Paclitaxel Drug-Eluting Balloon Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Paclitaxel Drug-Eluting Balloon market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
